Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | V909Cfs*6 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TSC2 V909Cfs*6 indicates a shift in the reading frame starting at amino acid 909 and terminating 6 residues downstream causing a premature truncation of the 1807 amino acid Tsc2 protein (UniProt.org). V909Cfs*6 results in increased phosphorylation of S6k1 and Stat3 in cultured cells (PMID: 31454656), and therefore, is predicted to lead to a loss of Tsc2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 inact mut TSC2 V909Cfs*6 |
Transcript | NM_000548.5 |
gDNA | chr16:g.2076152dupT |
cDNA | c.2724dupT |
Protein | p.V909Cfs*6 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000548.4 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_024450413.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_017023616.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001406664.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001370405.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001370404.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_005255531.4 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_005255529.4 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001077183.3 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001114382 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522639 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522637.2 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001406665.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001077183 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001077183.2 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522640.2 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001406663.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_021055.3 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_017023618.1 | chr16:g.2084236_2084237insTGCCCCCCCCCCCCCTA | c.2724_2725insTGCCCCCCCCCCCCCTA | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522640 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522636 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_005255529 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_017023615 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_017023615.1 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001363528.2 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_017023616 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_005255531 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522637.3 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522637 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_000548 | chr16:g.2076148_2076149insC | c.2720_2721insC | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_017023618 | chr16:g.2084235_2084236insCTGCCCCCCCCCCCCCT | c.2723_2724insCTGCCCCCCCCCCCCCT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522639.3 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522639.2 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2076152dupT | c.2724dupT | p.V909Cfs*6 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|